The diagnosed incidence of neuroendocrine tumors (NETs) is increasing. In fact, the data shows there has been a 5 fold rise over the last 30 years.  As a result, a vast number of NET patients are seeking care from physicians who may have little knowledge or experience with these diseases. Additionally, the treatment options for patients with neuroendocrine tumors are rapidly being developed. Therefore, there is a clear need to inform community physicians and allied health care providers across the US of the new advances in the field.

To address this educational deficit, NANETS has created a regional conference program. The one day event focuses on the standard management of patients with neuroendocrine tumors, sequence of treatments and new therapeutic approaches to these diseases.

Our goal for these conferences is to partner with centers to further develop regional NET teams, increase patient access to clinical trials and improve the ability for NET patients to receive a comprehensive, multidisciplinary management plan. 


Accreditation & Designation Statement: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of The University of Texas Southwestern Medical Center and the North American Neuroendocrine Tumor Society.  The University of Texas Southwestern Medical Center is accredited by the ACCME to provide continuing medical education for physicians.

The University of Texas Southwestern Medical Center designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Location & Accommodations: The symposium is being held at the Dallas Marriott Suites Medical/Market Center * 2493 North Stemmons Freeway * Dallas, Texas 75207.  For reservations phone: 1-214-905-0050 and mention your attendance at the NANETS conference.  

Agenda and Faculty:


Share this post